Clínica Baviera (CBAV) Stock Overview
A medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
CBAV Community Fair Values
Create NarrativeSee what 25 others think this stock is worth. Follow their fair value or set your own to get alerts.
Top Community Narratives
Clínica Baviera, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €56.00 |
| 52 Week High | €61.80 |
| 52 Week Low | €38.10 |
| Beta | 0.76 |
| 1 Month Change | 0.36% |
| 3 Month Change | 11.55% |
| 1 Year Change | 45.08% |
| 3 Year Change | 220.00% |
| 5 Year Change | 294.37% |
| Change since IPO | 147.13% |
Recent News & Updates
Recent updates
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
Baviera: Europe's Most Capital-Efficient Eye Care Compounder — Trading at Distressed Multiples While Delivering 15% CAGR and 40% ROCE. Fair Value €88/share ### The Business Clínica Baviera is Europe's leading specialist ophthalmology clinic network, focused on laser vision correction and intraocular surgery.We Think Clínica Baviera (BME:CBAV) Can Manage Its Debt With Ease
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...A Piece Of The Puzzle Missing From Clínica Baviera, S.A.'s (BME:CBAV) Share Price
With a price-to-earnings (or "P/E") ratio of 13x Clínica Baviera, S.A. ( BME:CBAV ) may be sending bullish signals at...Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings
Clínica Baviera, S.A.'s ( BME:CBAV ) price-to-earnings (or "P/E") ratio of 14.5x might make it look like a buy right...Clínica Baviera (BME:CBAV) Might Become A Compounding Machine
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405
The board of Clínica Baviera, S.A. ( BME:CBAV ) has announced that it will pay a dividend of €0.405 per share on the...Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?
Most readers would already be aware that Clínica Baviera's (BME:CBAV) stock increased significantly by 28% over the...Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return
It might be of some concern to shareholders to see the Clínica Baviera, S.A. ( BME:CBAV ) share price down 16% in the...Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. Having...Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Shareholder Returns
| CBAV | ES Healthcare | ES Market | |
|---|---|---|---|
| 7D | -5.7% | 1.0% | 2.1% |
| 1Y | 45.1% | -10.3% | 30.1% |
Return vs Industry: CBAV exceeded the Spanish Healthcare industry which returned -10.3% over the past year.
Return vs Market: CBAV exceeded the Spanish Market which returned 30.1% over the past year.
Price Volatility
| CBAV volatility | |
|---|---|
| CBAV Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in ES Market | 6.7% |
| 10% least volatile stocks in ES Market | 0.9% |
Stable Share Price: CBAV has not had significant price volatility in the past 3 months compared to the Spanish market.
Volatility Over Time: CBAV's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,592 | Eduardo Baviera Sabater | www.clinicabaviera.com |
Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services.
Clínica Baviera, S.A. Fundamentals Summary
| CBAV fundamental statistics | |
|---|---|
| Market cap | €897.04m |
| Earnings (TTM) | €42.06m |
| Revenue (TTM) | €304.91m |
Is CBAV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBAV income statement (TTM) | |
|---|---|
| Revenue | €304.91m |
| Cost of Revenue | €153.93m |
| Gross Profit | €150.98m |
| Other Expenses | €108.92m |
| Earnings | €42.06m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.63 |
| Gross Margin | 49.52% |
| Net Profit Margin | 13.80% |
| Debt/Equity Ratio | 7.1% |
How did CBAV perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/14 22:19 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Clínica Baviera, S.A. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| León Izuzquiza Lenze | Banco de Sabadell. S.A. |
| Marta Diaz | Banco de Sabadell. S.A. |
| Bosco Muguiro Eulate | Banco Santander |